The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML : an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1573105975872476160
  • NII論文ID
    10026111554
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ